Proliferation precedes differentiation in IGF-I-stimulated myogenesis

Journal of Cell Biology

Volumn 135, Issue 2, 1996, Pages 431-440

  Engert, James C ^a,b   Berglund, Erick B ^b   Rosenthal, Nadia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION; MUSCLE DEVELOPMENT; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REPORTER; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SKELETAL; MYOGENIN; MYOSIN LIGHT CHAINS; RATS; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION;

EID: 0029958679     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.135.2.431     Document Type: Article

References (81)

1. Ballard, F.J., L.C. Read, G.L. Francis, C.J. Bagley, and J.C. Wallace. 1986. Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. Biochem. J. 233:223-230.
2. Barres, B.A., R. Schmid, M. Sendnter, and M.C. Raff. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development (Camb.). 118:283-295.
3. Beck, F., N.J. Samani, J.D. Penschow, B. Thorley, G.W. Tregear, and J.P. Coghlan. 1987. Histochemical localization of IGF-I and -II mRNA in the developing rat embryo. Development (Camb.). 101:175-184.
4. Bondy, C.A., H. Werner, C.T. Roberts, Jr., and D. LeRoith. 1990. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol. Endocrinol. 4:1386-1398.
5. Braun, T., E. Bober, G. Buschhausen-Denker, S. Kohtz, K.H. Grzeschik, and H.H. Arnold. 1989. Differential expression of myogenic determination genes in muscle cells: possible autoactivalion by the Myf gene products (published erratum appears in EMBO (Eur. Mol. Biol. Organ.) J. 1989. Dec;8[13]:4358). EMBO Eur. Mol. Biol. Organ.) J. 8:3617-3625.
6. Chen, Y., K.E. Bornfeldt, A. Arner, E. Jennische, (J. Malmqvist, B. Uvelius, and H.J. Arnqvist. 1994. Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am. J. Physiol. 266:E224-229.
7. Coleman, M.E., F. DeMayo, K.C. Yin, H.M. Lee, R. Geske, C. Montgomery, and R.J. Schwartz. 1995. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270:12109-12116.
8. Czech, M.P. 1989. Signal transmission by the insulin-like growth factors. Cell. 59:235-238.
9. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:987-1000.
10. Donoghue, M., H. Ernst, B. Wentworth, B. Nadal-Ginard, and N. Rosenthal. 1988. A muscle-specific enhancer is located at the 3′ end of the myosin light-chain 1/3 gene locus. Genes & Dev. 2:1779-1790.
11. Edmondson, D.G., and E.N. Olson. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program (published erratum appears in Genes & Dev. 1990. Aug;4[8]:1450). Genes & Dev. 3:628-640.
12. Edmondson, S.R., G.A. Werther, A. Russell, D. LeRoith, C.T. Roberts, Jr., and F. Beck. 1995. Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: relationship to insulin-like growth factor-I mRNA. Endocrinology. 136: 4602-4609.
13. Edwall, D., M. Schalling, E. Jennische, and G. Norstedt. 1989. Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology. 124:820-825.
14. Ewton, D.Z., and J.R. Florini. 1981. Effects of the somatomedins and insulin on myoblast differentiation in vitro. Dev. Biol. 86:31-39.
15. Ewton, D.Z., S.L. Falen, and J.R. Florini. 1987. The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology. 120:115-123.
16. Ewton, D.Z., S.L. Roof, K.A. Magri, F.J. McWade, and J.R. Florini. 1994. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J. Cell. Physiol. 161:277-284.
17. Florini, J.R., and D.Z. Ewton. 1990. Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. J. Biol. Chem. 265:13435-13437.
18. Florini, J.R., D.Z. Ewton, M.J. Evinger-Hodges, S.L. Falen, R.L. Lau, J.F. Regan, and B.M. Vertel. 1984. Stimulation and inhibition of myoblast differentiation by hormones. In Vitro. 20:942-958.
19. Florini, J.R., D.Z. Ewton, S.L. Falen, and J.J. Van Wyk. 1986. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am. J. Physiol. 250:C771-778.
20. Florini, J.R., D.Z. Ewton, and K.A. Magri. 1991. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 53:201-215.
21. Florini, J.R., D.Z. Ewton, and S.L. Roof. 1991. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5:718-724.
22. Florini, J.R., K.A. Magri, D.Z. Ewton, P.L. James, K. Grindstaff, and P.S. Rotwein. 1991. "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:15917-15923.
23. Florini, J.R., D.Z. Ewton, K.A. Magri, and F.J. Mangiacapra. 1994. IGFS and muscle differentiation. In Current Directions in Insulin-like Growth Factor Research. D. LeRoith and M.K. Raizada, editors. Plenum Press, New York. 319-326.
24. Fuchtbauer, E.M., and H. Westphal. 1992. MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse. Dev. Dyn. 193:34-39.
25. Furlanetto, R.W., S.E. Harwell, and K.K. Frick. 1994. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol. 8:510-517.
26. Garfinkel, L.I., M. Periasamy, and B. Nadal-Ginard. 1982. Cloning and characterization of cDNA sequences corresponding to myosin light chains 1,2, and 3, troponin-C, troponin-T, alpha-tropomyosin, and alpha-actin. J. Biol. Chem. 257:11078-11086.
27. Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.). 366:707-710.
28. Guo, K., J. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
29. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD (see comments). Science (Wash. DC). 267:1018-1021.
30. Han, V.K., A.J. D'Ercole, and P.K. Lund. 1987. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science (Wash. DC). 236:193-197.
31. Han, V.K., D.J. Hill, A.J. Strain, A.C. Towle, J.M. Lauder, L.E. Underwood, and A.J. D'Ercole. 1987. Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus. Pediatr. Res. 22:245-249.
32. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805-816.
33. Harrington, E.A., M.R. Bennett, A. Fanidi, and G.I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO (Eur. Mol. Biol. Organ.) J. 13:3286-3295.
34. Ito, H., M. Hiroe, Y. Hirata, M. Tsujino, S. Adachi, M. Shichiri, A. Koike, A. Nogami, and F. Marumo. 1993. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation. 87:1715-1721.
35. Jahn, L., J. Sadoshima, and S. Izumo. 1994. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp. Cell Res. 212:297-307.
36. Jennische, E., and H.A. Hansson. 1987. Regenerating skeletal muscle cells express insulin-like growth factor I. Acta Physiol. Scand. 130:327-332.
37. Jennische, E., and H. Olivecrona. 1987. Transient expression of insulin-like growth factor I immunoreactivity in skeletal muscle cells during postnatal development in the rat. Acta Physiol. Scand. 131:619-622.
38. Jennische, E., A. Skottner, and H.A. Hansson. 1987. Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol. Scand. 129:9-15.
39. Kiess, M., R.M. Gill, and P.A. Hamel. 1995. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 10:159-166.
40. Lassar, A.B., S.X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
41. Lipton, B.H., and E. Schultz. 1979. Developmental fate of skeletal muscle satellite cells. Science (Wash. DC). 205:1292-1294.
42. Liu, J.P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
43. Lowe, W.L. 1991. Biological actions of the insulin-like growth factors. In Insulin-like Growth Factors: Molecular and Cellular Aspects. D. LeRoith, editor. CRC Press, Boca Raton, FL. 49-72.
44. Mangiacapra, F.J., S.L. Roof, D.Z. Ewton, and J.R. Florini. 1992. Paradoxical decrease in myf-5 messenger RNA levels during induction of myogenic differentiation by insulin-like growth factors. Mol Endocrinol. 6: 2038-2044.
45. Matsushime, H., M.F. Roussel, R.A. Ashmun, and C.J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:701-713.
46. Mauro, A. 1961. Satellite cells of skeletal muscle fibers. J Biophys. Biochem. Cytol. 9:493-495.
47. McClearn, D., R. Medville, and D. Noden. 1995. Muscle cell death during the development of head and neck muscles in the chick embryo. Dev. Dyn. 202:365-377.
48. Medford, R.M., H.T. Nguyen, and B. Nadal-Ginard. 1983. Transcriptional and cell cycle-mediated regulation of myosin heavy chain gene expression during muscle cell differentiation. J. Biol. Chem. 258:11063-11073.
49. Nadal-Ginard, B. 1978. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell. 15: 855-864.
50. Pajak, L., M. Mariappan, and D.F. Wieczorek. 1991. Reprogramming of myosin light chain 1/3 expression in muscle heterokaryons. Dev. Biol. 145:28-39.
51. Pardee, A.B. 1989. G1 events and regulation of cell proliferation. Science (Wash. DC). 246:603-608.
52. Parker, S.B., G. Eichele, P. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells (see comments). Science (Wash. DC). 267:1024-1027.
53. Periasamy, M., E.E. Strehler, L.I. Garfinkel, R.M. Cubits, N. Ruiz-Opazo, and B. Nadal-Ginard. 1984. Fast skeletal muscle myosin light chains 1 and 3 are produced from a single gene by a combined process of differential RNA transcription and splicing. J. Biol. Chem. 259:13595-13604.
54. Quinn, L.S., and J.S. Roh. 1993. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation. Exp. Cell Res. 208:504-508.
55. Rao, S.S., and D.S. Kohtz. 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:4093-4100.
56. Rao, S.S., C. Chu, and D.S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
57. Rhodes, S.J., and S.F. Konieczny. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes & Dev. 3: 2050-2061.
58. Roeder, R.A., K.L. Hossner, R.G. Sasser, and J.M. Gunn. 1988. Regulation of protein turnover by recombinant human insulin-like growth factor-I in L6 myotube cultures. Horm. Metab. Res. 20:698-700.
59. Rosen, K.M., B.M. Wentworth, N. Rosenthal, and L. Villa-Komaroff. 1993. Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. Endocrinology. 133:474-481.
60. Rosenthal, N. 1987. Identification of regulatory elements with functional assays. In Methods in Enzymology. S.L. Berger and A.R. Kimmel, editors. Academic Press, Boston, MA. 704-720.
61. Rosenthal, S.M., and Z.Q. Cheng. 1995. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc. Natl. Acad. Sci. USA. 92:10307-10311.
62. Rosenthal, N., J.M. Kornhauser, M. Donoghue, K.M. Rosen, and J.P. Merlie. 1989. Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA. 86:7780-7784.
63. Rosenthal, N., E.B. Berglund, B.M. Wentworth, M. Donoghue, B. Winter, E. Bober, T. Braun, and H.H. Arnold. 1990. A highly conserved enhancer downstream of the human MLC1/3 locus is a target for multiple myogenic determination factors. Nucleic Acids Res. 18:6239-6246.
64. Schneider, J.W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science (Wash. DC). 264:1467-1471.
65. Sherr, C.J. 1994. G1 phase progression: cycling on cue (see comments). Cell. 79:551-555.
66. Sicinski, P., J.L. Donaher, S.B. Parker, T. Li, A. Fazeli, H. Gardner, S.Z. Haslam, R.T. Bronson, S.J. Elledge, and R.A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:621-630.
67. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase (see comments). Science (Wash. DC). 267:1022-1024.
68. Smith, J., G. Fowkes, and P.N. Schofield. 1995. Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. Cell Death Differ. 2:243-252.
69. Strehler, E.E., M. Periasamy, M.A. Strehler-Page, and B. Nadal-Ginard. 1985. Myosin light-chain 1 and 3 gene has two structurally distinct and differentially regulated promoters evolving at different rates. Mol. Cell. Biol. 5:3168-3182.
70. Sussenbach, J.S. 1989. The gene structure of the insulin-like growth factor family. Prog. Growth Factor Res. 1:33-48.
71. Tollefsen, S.E., R. Lajara, R.H. McCusker, D.R. Clemmons, and P. Rotwein. 1989. Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J. Biol. Chem. 264:13810-13817.
72. Tollefsen, S.E., J.L. Sadow, and P. Rotwein. 1989. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. USA. 86:1543-1547.
73. Turo, K.A., and J.R. Florini. 1982. Hormonal stimulation of myoblast differentiation in the absence of DNA synthesis. Am. J. Physiol. 243: C278-284.
74. Vandenburgh, H.H., P. Karlisch, J. Shansky, and R. Feldstein. 1991. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am. J. Physiol. 260:C475-484.
75. Wang, J., and B. Nadal-Ginard. 1995. Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206:82-88.
76. Wentworth, B.M., M. Donoghue, J.C. Engert, E.B. Berglund, and N. Rosenthal. 1991. Paired MyoD-binding sites regulate myosin light chain gene expression. Proc. Natl. Acad. Sci. USA. 88:1242-1246.
77. Winston, J.T., and W.J. Pledger. 1993. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol. Biol. Cell. 4:1133-1144.
78. Won, K.A., Y. Xiong, D. Beach, and M.Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA. 89:9910-9914.
79. Wright, W.E., D.A. Sassoon, and V.K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 56:607-617.
80. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases (see comments). Nature (Lond.). 366:701-704.
81. Yaffe, D. 1968. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA. 61:477-483.